Adil Aftab: Acute VTE Treatment and Anticoagulation Considerations in Renal Dysfunction
Adil Aftab, Postgraduate Trainee at People’s University of Medical and Health Sciences for Women, Nawabshah, shared a post on LinkedIn:
“Acute DVT or PE (VTE) Treatment, Anticoagulation and Renal Function
Anticoagulation is the cornerstone of acute venous thromboembolism management. Choosing the right agent requires careful consideration of renal function, bleeding risk, drug interactions, clinical stability, and patient preference.
This quick reference chart highlights commonly used options including Apixaban, Rivaroxaban, Edoxaban, Dabigatran, LMWH, and UFH, with important renal function considerations.
Key clinical points:
- Use Cockcroft Gault CrCl when making anticoagulant dosing decisions.
- Reassess renal function regularly.
- UFH is often preferred when renal function is unstable or bleeding risk is high.
- DOAC selection should be individualized according to renal function and clinical circumstances.
- Always assess contraindications and situations requiring temporary interruption of anticoagulation.
Continuous learning and evidence based prescribing are essential for safe VTE management.”
Stay updated with Hemostasis Today.
-
Oct 27, 2026, 23:04Stefano Navarro: Hypertension Reprogrammes Megakaryocytes and Increases Platelet Responsiveness to Thrombin
-
Oct 27, 2026, 23:03Enrique M. San Norberto García: What Is the Best Treatment for Femoropopliteal in-Stent Restenosis
-
Oct 27, 2026, 23:01Mandy-Lyn Crispim: One Donation Can Help Save More Than One Life
-
Oct 27, 2026, 23:00Teresa Buzzoni: AABB 2026 Through the Eyes of a Newcomer to the Blood Industry
-
Oct 27, 2026, 22:59Josephine Cantu: The Incredible Science Behind Blood Clotting – A Life-Saving Process
-
Oct 27, 2026, 22:56Edward Lee Carter: First Factor XIa Inhibitor Approved Worldwide – U.S. FDA Decision Expected in November
-
Oct 27, 2026, 22:56Anne Troldborg: Preventing Thrombosis in SLE Before the First Event
-
Oct 27, 2026, 22:53Shadi Tabibian: Tazehnameh November 2026 Covers Key Developments in Hemophilia Care
-
Oct 27, 2026, 22:52Danny Hsu: THANZ Makes History With Its First Dedicated HHT Symposium at Blood 2026